Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN\METFORMIN Cause Weight increased? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Weight increased have been filed in association with EMPAGLIFLOZIN\METFORMIN. This represents 0.3% of all adverse event reports for EMPAGLIFLOZIN\METFORMIN.

8
Reports of Weight increased with EMPAGLIFLOZIN\METFORMIN
0.3%
of all EMPAGLIFLOZIN\METFORMIN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Weight increased From EMPAGLIFLOZIN\METFORMIN?

Of the 8 reports.

Is Weight increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN\METFORMIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN\METFORMIN Cause?

Diabetic ketoacidosis (312) Blood glucose increased (157) Euglycaemic diabetic ketoacidosis (156) Vomiting (149) Weight decreased (143) Ketoacidosis (139) Nausea (128) Diarrhoea (101) Dizziness (84) Fournier's gangrene (71)

What Other Drugs Cause Weight increased?

ADALIMUMAB (7,724) INFLIXIMAB (7,639) PREDNISONE (7,348) RISPERIDONE (6,885) METHOTREXATE (6,616) TOCILIZUMAB (6,425) RITUXIMAB (6,148) TOFACITINIB (5,342) ETANERCEPT (5,327) PREGABALIN (4,903)

Which EMPAGLIFLOZIN\METFORMIN Alternatives Have Lower Weight increased Risk?

EMPAGLIFLOZIN\METFORMIN vs EMSAM EMPAGLIFLOZIN\METFORMIN vs EMTRICITABINE EMPAGLIFLOZIN\METFORMIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE EMPAGLIFLOZIN\METFORMIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL EMPAGLIFLOZIN\METFORMIN vs EMTRICITABINE\TENOFOVIR

Related Pages

EMPAGLIFLOZIN\METFORMIN Full Profile All Weight increased Reports All Drugs Causing Weight increased EMPAGLIFLOZIN\METFORMIN Demographics